Research graph
References from Gut microbiota and metabolic alterations in participants with flatulence identify Faecalibacterium prausnitzii as a key microbial target for clinical intervention. Local targets link to admitted publications; unresolved targets remain external evidence.
Investigation of normal flatus production in healthy volunteers
10.1136/gut.32.6.665 · 1991 · External reference
Anal gas evacuation and colonic microbiota in patients with flatulence: effect of diet
10.1136/gutjnl-2012-303013 · 2014 · External reference
Abdominal bloating and distension: what is the role of the microbiota
10.1007/s10620-011-1834-4 · 2012 · External reference
Frequency of functional bowel disorders among healthy volunteers in Mexico City
10.1159/000092887 · 2006 · External reference
A survey of irritable bowel syndrome in Vietnam using the Rome criteria
10.1007/s10620-005-9005-0 · 2006 · External reference
The gut microbiota and host health: a new clinical frontier
10.1136/gutjnl-2015-309990 · 2016 · External reference
Molecular characterization of the intestinal microbiota in patients with and without abdominal bloating
10.1152/ajpgi.00044.2015 · 2016 · External reference
A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating
10.1111/j.1365-2982.2005.00695.x · 2005 · External reference
A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention
10.1111/j.1365-2036.2005.02579.x · 2005 · External reference
Bifidobacterium animalis subsp. lactis Bi-07 supports lactose digestion in vitro and in randomized, placebo- and lactase-controlled clinical trials
10.1093/ajcn/nqac264 · 2022 · External reference
Probiotic bacteria lactobacillus acidophilus NCFM and bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders: a double-blind study
10.1097/mcg.0b013e31820ca4d6 · 2011 · External reference
The use of lactobacillus GG in irritable bowel syndrome in children: a double-blind randomized control trial
10.1016/j.jpeds.2005.05.015 · 2005 · External reference
The efficacy of lactobacillus reuteri ATCC 55730 in the treatment of patients with irritable bowel syndrome—A double blind, placebo-controlled, randomized study
10.1016/j.clnu.2005.06.001 · 2005 · External reference
Effect of a prebiotic galactooligosaccharide mixture (B-GOS®) on gastrointestinal symptoms in adults selected from a general population who suffer with bloating, abdominal pain, or flatulence
10.1111/nmo.13440 · 2018 · External reference
Efficacy and safety of spore-forming probiotics in the treatment of functional dyspepsia: a pilot randomised, double-blind, placebo-controlled trial
10.1016/s2468-1253(21)00226-0 · 2021 · External reference
C. The effect of a probiotic blend on gastrointestinal symptoms in constipated patients: a double blind, randomised, placebo controlled 2-week trial
10.3920/bm2018.0163 · 2019 · External reference
Effects of prebiotics vs a diet low in FODMAPs in patients with functional gut disorders
10.1053/j.gastro.2018.06.045 · 2018 · External reference
Efficacy, safety, and tolerability of fructooligosaccharides in the treatment of irritable bowel syndrome
10.1093/ajcn/72.6.1570 · 2000 · External reference
Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence
10.1016/j.cgh.2008.02.058 · 2008 · External reference
Effect of synbiotic in constipated adult women—A randomized, double-blind, placebo-controlled study of clinical response
10.1016/j.clnu.2012.08.010 · 2013 · External reference
Extensive personal human gut microbiota culture collections characterized and manipulated in gnotobiotic mice
10.1073/pnas.1102938108 · 2011 · External reference
Design and investigation of PolyFermS in vitro continuous fermentation models inoculated with immobilized fecal microbiota mimicking the elderly colon
10.1371/journal.pone.0142793 · 2015 · External reference
Both living and dead faecalibacterium prausnitzii alleviate house dust mite-induced allergic asthma through the modulation of gut microbiota and short-chain fatty acid production
10.1002/jsfa.11207 · 2021 · External reference
In vitro selection of probiotics for microbiota modulation in normal-weight and severely obese individuals: focus on gas production and interaction with intestinal epithelial cells
10.3389/fmicb.2021.630572 · 2021 · External reference
Improved metagenome binning and assembly using deep variational autoencoders
10.1038/s41587-020-00777-4 · 2021 · External reference
Microeco: an R package for data mining in microbial community ecology
10.1093/femsec/fiaa255 · 2021 · External reference
A key genetic factor governing arabinan utilization in the gut microbiome alleviates constipation
10.1016/j.chom.2023.10.011 · 2023 · External reference
Gut microbiome alterations in high-fat-diet-fed mice are associated with antibiotic tolerance
10.1038/s41564-021-00912-0 · 2021 · External reference
Prevalence, characteristics, and impact of bloating symptoms in patients with irritable bowel syndrome
10.1016/j.cgh.2008.07.008 · 2009 · External reference
Prevalence and risk factors for abdominal bloating and visible distention: a population-based study
10.1136/gut.2007.142810 · 2008 · External reference
Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome
10.1126/scitranslmed.aap8914 · 2018 · External reference
Gut microbiota in patients with irritable bowel syndrome—A systematic review
10.1053/j.gastro.2019.03.049 · 2019 · External reference
Differences in gut microbiota in patients with vs without inflammatory bowel diseases: a systematic review
10.1053/j.gastro.2019.11.294 · 2020 · External reference
Decreased diversity of the fecal microbiome in recurrent clostridium difficile—Associated diarrhea
10.1086/525047 · 2008 · External reference
Diversity, stability and resilience of the human gut microbiota
10.1038/nature11550 · 2012 · External reference
Altered composition of gut microbiota in depression: a systematic review
10.3389/fpsyt.2020.00541 · 2020 · External reference
A double-blind, 377-subject randomized study identifies ruminococcus, coprococcus, christensenella, and collinsella as long-term potential key players in the modulation of the gut microbiome of lactose intolerant individuals by galacto-oligosaccharides
10.1080/19490976.2021.1957536 · 2021 · External reference
Nongastric helicobacter species detected in the intestinal tract of children
10.1128/jcm.02017-05 · 2006 · External reference
Gut microbial metabolites and biochemical pathways involved in irritable bowel syndrome: effects of diet and nutrition on the microbiome
10.1093/jn/nxz302 · 2020 · External reference
Potential health benefits of lowering gas production and bifidogenic effect of the blends of polydextrose with inulin in a human gut model
10.3389/fnut.2022.934621 · 2022 · External reference
Formation of propionate and butyrate by the human colonic microbiota
10.1111/1462-2920.13589 · 2017 · External reference
Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine
10.1111/j.1574-6968.2009.01514.x · 2009 · External reference
Increasing evidence that irritable bowel syndrome and functional gastrointestinal disorders have a microbial pathogenesis
10.3389/fcimb.2020.00468 · 2020 · External reference
Altered profiles of intestinal microbiota and organic acids May be the origin of symptoms in irritable bowel syndrome
2010 · External reference
Fecal clostridiales distribution and short-chain fatty acids reflect bowel habits in irritable bowel syndrome
10.1111/1462-2920.14271 · 2018 · External reference
Two microbiota subtypes identified in irritable bowel syndrome with distinct responses to the low FODMAP diet
10.1136/gutjnl-2021-325177 · 2022 · External reference
Revealing the bacterial butyrate synthesis pathways by analyzing (meta) genomic data
10.1128/mbio.00889-14 · 2014 · External reference
H2 generated by fermentation in the human gut microbiome influences metabolism and competitive fitness of gut butyrate producers
10.1186/s40168-023-01565-3 · 2023 · External reference
Contribution of acetate to butyrate formation by human faecal bacteria
10.1079/bjn20041150 · 2004 · External reference
Effect of fructooligosaccharides supplementation on the gut microbiota in human: a systematic review and meta-analysis
10.3390/nu14163298 · 2022 · External reference
Effect of chicory-derived inulin-type fructans on abundance of bifidobacterium and on bowel function: a systematic review with meta-analyses
10.1080/10408398.2022.2098246 · 2023 · External reference
Unique sugar metabolic pathways of bifidobacteria
10.1271/bbb.100494 · 2010 · External reference
Bifidobacterial inulin-type fructan degradation capacity determines cross-feeding interactions between bifidobacteria and faecalibacterium prausnitzii
10.1016/j.ijfoodmicro.2016.05.015 · 2016 · External reference
Cross-feeding between bifidobacteria and butyrate-producing colon bacteria explains bifdobacterial competitiveness, butyrate production, and gas production
10.1016/j.ijfoodmicro.2011.03.003 · 2011 · External reference
Is the abundance of faecalibacterium prausnitzii relevant to crohn’s disease?
10.1111/j.1574-6968.2010.02057.x · 2010 · External reference
